Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.

Saletu-Zyhlarz GM, Anderer P, Wolzt M, Semlitsch HV, Assandri A, Nessi P, Nannipieri F, Rosini S, Saletu B.

Neuropsychobiology. 2009;59(2):100-9. doi: 10.1159/000212379.

PMID:
19365150
2.
3.

Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.

Anderer P, Saletu B, Wolzt M, Culic S, Assandri A, Nannipieri F, Rosini S, Saletu-Zyhlarz GM.

Hum Psychopharmacol. 2008 Apr;23(3):243-54. doi: 10.1002/hup.920.

PMID:
18181252
4.

Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.

Arnold O, Saletu B, Anderer P, Assandri A, di Padova C, Corrado M, Saletu-Zyhlarz GM.

Eur Neuropsychopharmacol. 2005 Oct;15(5):533-43.

PMID:
16046102
5.

Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.

Saletu B, Grünberger J, Linzmayer L, Wittek R.

Arch Gerontol Geriatr. 1984 Jul;3(2):127-46.

PMID:
6476974
6.
8.

On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.

Saletu B, Grünberger J, Linzmayer L.

Int J Clin Pharmacol Ther Toxicol. 1989 Feb;27(2):51-65.

PMID:
2921096
9.
10.
11.
12.

Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.

Saletu B, Grünberger J, Linzmayer L.

Int Clin Psychopharmacol. 1986 Apr;1(2):145-64.

PMID:
2883214
13.
14.

Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.

Saletu B, Grünberger J, Linzmayer L.

Methods Find Exp Clin Pharmacol. 1986 Jun;8(6):373-89.

PMID:
3736281
15.

Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.

Saletu B, Grünberger J, Linzmayer L, Anderer P.

Pharmacopsychiatry. 1987 Feb;20(1 Spec No):12-27.

PMID:
2883677
16.

Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.

Saletu B, Grünberger J.

Methods Find Exp Clin Pharmacol. 1984 Jun;6(6):317-30.

PMID:
6431211
17.

Pharmaco-EEG, behavioural methods and blood levels in the comparison of temazepam and flunitrazepam.

Saletu B, Grünberger J, Sieghart W.

Acta Psychiatr Scand Suppl. 1986;332:67-94.

PMID:
2883830
18.

Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.

Saletu B, Grünberger J, Linzmayer L, Dubini A.

Int J Clin Pharmacol Ther Toxicol. 1983 Oct;21(10):489-95.

PMID:
6139346
19.

[Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].

Saletu B, Grünberger L, Linzmayer L, Wittek R, Stöhr H.

Wien Klin Wochenschr. 1983 Jul 8;95(14):481-93. German.

PMID:
6356628
20.

Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.

Saletu B, Grünberger J, Linzmayer L.

Methods Find Exp Clin Pharmacol. 1980 Oct;2(5):269-85.

PMID:
6927816
Items per page

Supplemental Content

Support Center